NeuroPace Q2 revenue $22.8M (+17% YoY); raises FY26 revenue guidance

NeuroPace Inc

Q2 2026 RNS revenue $22.5M, up 21.3% YoY; total revenue $22.8M vs $19.5M in Q2 2025.
GAAP net loss narrowed to ($6.2)M from ($10.0)M YoY; Adjusted EBITDA loss improved to ($2.8)M from ($4.9)M.
FY26 revenue guidance raised to $99.5M-$101.5M (from $99M-$101M); Adjusted EBITDA guided to ($7.5)M-($8.5)M.
Launched ECoG Assistant AI decision-support tool; NAUTILUS 18-month data showed 77% median GTC seizure reduction.
Cash $51.9M at June 30, 2026; DIXI product operations presented as discontinued; long-term borrowings $59.0M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.